ArticleCancers2020

Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand.

Chen-Tzu Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.